Finedon, United Kingdom

Victoria Richardson

This inventor holds 1 USPTO granted patent. Top assignee: Medimmune Limited. Active years: 2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Victoria Richardson. Retrieved from https://idiyas.com/inventor/victoria-richardson

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2015

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Victoria Richardson: Innovator in Biotechnology

Introduction

Victoria Richardson is a prominent inventor based in Finedon, GB. She has made significant contributions to the field of biotechnology, particularly in the development of cell lines for recombinant protein production. Her work has implications for various applications in medicine and research.

Latest Patents

Victoria holds a patent related to a Chinese hamster ovary cell line, which is deposited with the European Collection of Cell Cultures (ECACC) under accession number 10090201. This invention encompasses the use of the cell line for the production of a recombinant polypeptide, a kit comprising the cell line, and methods for the production of recombinant polypeptide. This patent highlights her innovative approach to biopharmaceutical development.

Career Highlights

Victoria is currently employed at MedImmune Limited, where she continues to advance her research in biotechnology. Her expertise in cell line development has positioned her as a valuable asset in her field.

Collaborations

Some of her notable coworkers include Diane Hatton and Wyn Forrest-Owen, who contribute to the collaborative environment at MedImmune Limited.

Conclusion

Victoria Richardson's work exemplifies the intersection of innovation and biotechnology, showcasing her dedication to advancing medical research through her patented inventions. Her contributions are vital to the ongoing development of biopharmaceuticals.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…